The BRC Seminar Series is back for Fall 2022! Date: 9/2/2022 Seminar: Valerie Tutwiler, Ph.D. Rutgers University, School of Engineering Title: ‘Enzymatic and structural stability of fibrin’ Location: POB Room PB3101
We are excited to announce that the 10th Annual Sickle Cell Disease Conference: Carolina Update, hosted collaboratively by University of North Carolina Chapel Hill Sickle Cell Disease Program and Duke University School of Nursing, is scheduled for two virtual sessions on Friday, September 16th, 2022 and Saturday, September 17th, 2022 from 9:45AM to 12:30PM. The … Read more
Date: 10/7/2022 Seminar: Cristina Puy, PhD Oregon Health and Science University Title: ‘Regulation of Vascular Permeability by Coagulation FXI’ Location: MEJ 3104
Date: 10/21/2022 Seminar: Jon Schoenecker, MD Vanderbilt University Medical Center Title: TBD Location: MEJ 3116
MDDate: 11/4/2022 Seminar: Saghi Ghaffari, MD Icahn School of Medicine at Mount Sinai Title: TBD Location: MEJ 3116
Date: 11/18/2022 Seminar: Chris Dockendorff, Ph.D. Function Therapeutics Title: TBD Location: MEJ 3116
Date: 12/2/2022 Seminar: Lucy Kornblith, MD University of California San Francisco Title: TBD Location: Virtual
The 64th ASH Annual Meeting and Exposition is scheduled to take place December 10-13, 2022 at the Ernest N. Morial Convention Center in New Orleans, Louisiana. This in-person event will be broadcast virtually and access to the meeting’s virtual platform is included with registration. REGISTER FOR THE MEETING
Date: 12/16/2022 Seminar: David Rees, MD King's College London Title: TBD Location: Virtual
Date: 2/3/2023 Seminar: Peter Lenting, PhD Inserm Title: ‘The use of mouse models to better understand the mode of action of emicizumab’ Location: Virtual
Date: 2/17/223 Seminar: Paula James, MD Queen's University - Ontario Title: ‘Von Willebrand Disease in 2023: BATs and Endothelial Cells' Location: Mary Ellen Jones building, Room 3116 Host: Nigel Key, MD
Date: 3/3/223 Seminar: Elisa Rossi, PhD University of Paris Title: TBD Location: Virtual
